JPH0212443B2 - - Google Patents
Info
- Publication number
- JPH0212443B2 JPH0212443B2 JP60087988A JP8798885A JPH0212443B2 JP H0212443 B2 JPH0212443 B2 JP H0212443B2 JP 60087988 A JP60087988 A JP 60087988A JP 8798885 A JP8798885 A JP 8798885A JP H0212443 B2 JPH0212443 B2 JP H0212443B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cells
- glucose
- sodium chloride
- osmotic pressure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 229920002307 Dextran Polymers 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 5
- 210000003491 skin Anatomy 0.000 description 26
- 230000000694 effects Effects 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 13
- 230000003204 osmotic effect Effects 0.000 description 12
- 210000004927 skin cell Anatomy 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000003792 electrolyte Substances 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 231100000360 alopecia Toxicity 0.000 description 5
- 210000003722 extracellular fluid Anatomy 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- -1 sodium chloride Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000002407 ATP formation Effects 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000003779 hair growth Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 208000000069 hyperpigmentation Diseases 0.000 description 3
- 230000003810 hyperpigmentation Effects 0.000 description 3
- 210000001700 mitochondrial membrane Anatomy 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000002344 surface layer Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009056 active transport Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 210000005061 intracellular organelle Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60087988A JPS61246130A (ja) | 1985-04-24 | 1985-04-24 | 水性皮膚及び毛髪化粧料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60087988A JPS61246130A (ja) | 1985-04-24 | 1985-04-24 | 水性皮膚及び毛髪化粧料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61246130A JPS61246130A (ja) | 1986-11-01 |
| JPH0212443B2 true JPH0212443B2 (fr) | 1990-03-20 |
Family
ID=13930191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60087988A Granted JPS61246130A (ja) | 1985-04-24 | 1985-04-24 | 水性皮膚及び毛髪化粧料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61246130A (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007151932A (ja) * | 2005-12-07 | 2007-06-21 | Transcutaneous Technologies Inc | イオントフォレーシス装置 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63229068A (ja) * | 1987-03-17 | 1988-09-22 | 新技術事業団 | 電気刺激創傷治療装置 |
| US5116605A (en) * | 1989-03-09 | 1992-05-26 | Alt John P | Composition and skin treatment method therewith for mitigating acne and male-pattern baldness |
| JPH05117158A (ja) * | 1991-10-22 | 1993-05-14 | Sasaki Kagaku Yakuhin Kk | 皮膚外用剤組成物 |
| GB9222772D0 (en) * | 1992-10-30 | 1992-12-09 | Unilever Plc | Cosmetic composition |
| JP2920611B2 (ja) * | 1995-12-11 | 1999-07-19 | 株式会社シーエーシー | 皮膚炎の治療外用剤 |
| JP2001139477A (ja) * | 1999-11-17 | 2001-05-22 | Coherent Technology:Kk | 創傷部位の組織細胞増殖促進液 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574854A (en) * | 1966-03-22 | 1971-04-13 | Francois J Bossard | Method for soothing the skin with a cream containing sodium chloride |
| US3777597A (en) * | 1970-04-29 | 1973-12-11 | Pharmachem Corp | Method of shaving employing an aqueous solution of dextran |
| US3859436A (en) * | 1968-10-02 | 1975-01-07 | Kolmar Laboratories | Sugar composition for topical application |
-
1985
- 1985-04-24 JP JP60087988A patent/JPS61246130A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3574854A (en) * | 1966-03-22 | 1971-04-13 | Francois J Bossard | Method for soothing the skin with a cream containing sodium chloride |
| US3859436A (en) * | 1968-10-02 | 1975-01-07 | Kolmar Laboratories | Sugar composition for topical application |
| US3777597A (en) * | 1970-04-29 | 1973-12-11 | Pharmachem Corp | Method of shaving employing an aqueous solution of dextran |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007151932A (ja) * | 2005-12-07 | 2007-06-21 | Transcutaneous Technologies Inc | イオントフォレーシス装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61246130A (ja) | 1986-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2681527B2 (ja) | 細胞活性促進外用剤 | |
| KR100950524B1 (ko) | 국소 글리코피롤레이트 제품 | |
| US5496827A (en) | Compositions for the transdermal delivery of nutrients | |
| US5853732A (en) | Pharmaceutical compositions containing kukui nut oil | |
| EP0308210A1 (fr) | Traitement topique des troubles de la peau malade | |
| KR100673044B1 (ko) | 경피 투여용 국소 조성물 | |
| US20060222689A1 (en) | Skin care compositions and methods | |
| US20110236503A1 (en) | Topical Skincare Composition | |
| JPH0212443B2 (fr) | ||
| CN103463627A (zh) | 一种含耐热超氧化物歧化酶和生长因子的口腔护理组合物 | |
| US20160101139A1 (en) | Topical treatment for use as a sleep aid | |
| JP2013163681A (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| JP2007332078A (ja) | オゾン溶存グリセリン溶液を含む化粧料、医薬部外品、医薬（医薬品）等の外用剤 | |
| JP5164438B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| EP1752132A2 (fr) | Compositions cosmétiques pour la peau | |
| JP5699184B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| JP2766811B2 (ja) | 水性皮膚外用剤 | |
| KR0141930B1 (ko) | 세포활성촉진 외용제 | |
| RU2325900C2 (ru) | Состав для кожи наружного применения | |
| ITLI20110005A1 (it) | Composizione per la cura della psoriasi e relative malattie cutanee | |
| US11969405B2 (en) | Method of treatment of topical dermatologic acne using a cream composition and method of manufacture | |
| JP5993336B2 (ja) | 二酸化炭素経皮・経粘膜吸収用組成物 | |
| KR20070006626A (ko) | 피부의 국부조성물 | |
| US20230055512A1 (en) | Method of treatment of topical dermatologic acne using a cream composition and method of manufacture | |
| RU2190388C1 (ru) | Средство на основе масла чайного дерева (варианты) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |